drugset / Trial / NCT02936895

Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia

NCT02936895

Phase 4 Completed 100 enrolled Hormozgan University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Childhood deaths from pneumonia is almost 2000 times higher in developing countries than in developed countries. In 1970, pneumonia was responsible for 9% of all deaths in children under 5 years. This rate was 2% in 2007. Some studies have shown that supplementing with vitamin D reduces disease of the respiratory tract infection. Some other studies have shown anti-inflammatory effect of vitamin D in cell lines. Studies about the role of vitamin D supplementation in pneumonia in children are inadequate to conclude about its role. The aim of this study is to determine the efficacy of vitamin D supplementation in Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of hospitalized patients with community-acquired pneumonia.

Timeline

Start
2015-01
Primary completion
2016-01
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 50000 iu

Indications